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BACKGROUND
Mitral Valve Prolapse (MVP) is caused by myxomatous valve leaflet 
changes. Malignant MVP is an understated cause of sudden cardiac 
death (SCD).
CASE
A 56 year old Female with history of MVP presented as a witnessed 
cardiac arrest while golfing. Patient received bystander CPR and was 
defibrillated once for Vfib with ROSC. EKG showed Non Sustained 
Ventricular Tachycardia (Figure 2). Patient completed therapeutic 
hypothermia with full neurologic recovery. Work up showed normal 
coronaries, Cardiac MRI with bileaflet MVP with moderate MR and 
mild inferobasilar scar (Figure 4), Mitral annular disjunction (Figure 5), 
normal ventricular size and systolic function.
EKG
CONCLUSION
The patient had a previous Holter monitor with 3.7% PVC 
burden; with couplets and one triplet (figure 3), and was 
started on B blockers. 
Malignant phenotype of MVP includes: 
•  Young women 
•  Bileaflet prolapse 
•  Biphasic or inverted T waves 
•  Complex ventricular ectopy.1 
The triad of substrate, trigger and transient excitation  
increase risk of SCD. MVP patients with scar have 7.7%  
risk of arrhythmic events compared to 2.5%.2
Overall risk for SCD has been described around 0.4%.  
The patient received an ICD for secondary prevention of SCD.
DISCUSSION
MVP has been associated with SCD, necessitating a formal 
risk stratification strategy. This includes Holter monitor, CMR 
for scar and more recently PET is being studied to detect 
stage of inflammation. Above information can be used to 
guide decision and timing for Mitral valve intervention. 
Additionally, successful treatment with catheter ablation  
has been described.
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Figure 2: EKG on arrival in Emergency Department.
Figure 3: Ventricular triplet demonstrated on Holter Monitor months prior to the event.
Figure 4: Cardiac MRI with late gadolinium 
enhancement, that is indicative of scar. 















Figure 1: Baseline EKG.
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